The department has always adhered to the concept of “refined management of chronic diseases and precise understanding of difficult diseases”, and carried out standardized “closed-loop of in-hospital and out-hospital” management for patients. The department takes the lead in remote management of diabetic patients in China and currently manages more than 4,000 diabetic patients online. Our department actively promotes MDT diagnosis and treatment of endocrine tumors, which combines with the strength of high-quality medical teams and formulates optimal diagnosis and treatment plans for patients. In addition to that, the department practices accurate diagnosis and treatment of difficult endocrine and metabolic diseases. This includes the diagnosis and management of nearly 50 rare and difficult diseases of endocrine metabolisms, such as wolfram syndrome, porphyria, maturity onset diabetes of the young, hemochromatosis, and congenital adrenal hyperplasia, making the Department of Endocrinology and Metabolism’s diagnosis and treatment capabilities highly recognized throughout the country.
Since its establishment, the Department of Endocrinology and Metabolism of the First Hospital of Jilin University has been continuously forging ahead and actively participating in domestic and foreign exchanges. The department is committed to the construction of excellent medical ethics and medical style, high-quality medical services, a reasonable discipline development structure, superb business ability, and advanced scientific research and innovation concepts. We are committed to establishing footholds in Changchun, serving Jilin Province, and radiating the services to three eastern provinces to provide an excellent learning platform for endocrinologists and health care to the people in the region.